Bristol Myers Squibb (CELG-RI) Cash from Operations (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has 18 years of Cash from Operations data on file, last reported at 1104000000.0 in Q1 2026.

• Cash from Operations for Q1 2026 came in at 1104000000.0, down 43.5% year-over-year; the trailing twelve-month figure through Mar 2026 was 13306000000.0 (down 7.02% YoY), and the FY2025 annual result was 14156000000.0, down 6.81% from the prior year.
• Cash from Operations slipped to 1104000000.0 in Q1 2026 per CELG-RI's latest filing, from 1974000000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 6311000000.0 in Q3 2025 and troughed at 1104000000.0 in Q1 2026.
• A 5-year average of 3375058823.53 and a median of 3306000000.0 in 2022 frame the typical range for Cash from Operations.
• On a YoY basis, Cash from Operations climbed as much as 68.4% in 2025 and fell as far as 55.53% in 2025.
• A 5-year view of Cash from Operations shows it stood at 3306000000.0 in 2022, then climbed by 28.61% to 4252000000.0 in 2023, then gained by 4.4% to 4439000000.0 in 2024, then plunged by 55.53% to 1974000000.0 in 2025, then plunged by 44.07% to 1104000000.0 in 2026.
• Business Quant data shows CELG-RI's Cash from Operations at 1104000000.0 in Q1 2026, 1974000000.0 in Q4 2025, and 6311000000.0 in Q3 2025.